Analyst Ratings for Inovio Pharmaceuticals (INO)

INO Rating Summary

INO Price Target Summary

* Over Last 12-Mos
  |   Expand Research on INO
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $5.00 (+157.7%) * Over Last 12-Mos
Rating Score: 4.7 / 10   Percentile Rank: 44%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/11/2022 Oppenheimer Hartaj Singh Downgrade Perform
(Outperform)
N/A
(N/A)
2.49
(1.94)
-22.09% Details
1/21/2022 BofA Securities
» Updated 5/17/2022
Geoff Meacham Upgrade Neutral
(Underperform)
8.00
(9.00)
4.10
(1.94)
-52.68% Details